ResMed (WBO:RMD) EV-to-EBITDA

: 19.43 (As of Today)

View and export this data going back to 2019. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ResMed's enterprise value is €25,765 Mil. ResMed's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €1,326 Mil. Therefore, ResMed's EV-to-EBITDA for today is 19.43.

The historical rank and industry rank for ResMed's EV-to-EBITDA or its related term are showing as below:

WBO:RMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.57 Med: 21.1 Max: 39.74
Current: 19.14

During the past 13 years, the highest EV-to-EBITDA of ResMed was 39.74. The lowest was 11.57. And the median was 21.10.

WBO:RMD's EV-to-EBITDA is ranked worse than
60.04% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 14.625 vs WBO:RMD: 19.14

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-19), ResMed's stock price is €167.10. ResMed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €5.614. Therefore, ResMed's PE Ratio for today is 29.76.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

ResMed EV-to-EBITDA Historical Data

The historical data trend for ResMed's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBITDA

26.43

28.93

32.98

26.20

24.81

ResMed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA																25.97	25.71	24.81	16.80	18.52

Competitive Comparison

For the Medical Instruments & Supplies subindustry, ResMed's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed EV-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ResMed's EV-to-EBITDA falls into.

ResMed EV-to-EBITDA Calculation

ResMed's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	25764.835	/	1326.243
	=	19.43

ResMed's current Enterprise Value is €25,765 Mil.
ResMed's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,326 Mil.

ResMed (WBO:RMD) EV-to-EBITDA Explanation

ResMed's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	167.10	/	5.614
	=	29.76

ResMed's share price for today is €167.10.
ResMed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.614.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

ResMed EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ResMed's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (WBO:RMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (WBO:RMD) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.